Michael Zdanowski
Corporate Officer/Principal at Medeor Therapeutics, Inc.
Net worth: 1 890 $ as of 2024-06-29
Network origin in Michael Zdanowski first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Extinct | Pharmaceuticals: Major | 10 | |
New York Stem Cell Foundation, Inc.
9
| Foundation/Endowment | Investment Trusts/Mutual Funds | 9 |
Medeor Therapeutics, Inc.
 Medeor Therapeutics, Inc. Medical/Nursing ServicesHealth Services Medeor Therapeutics, Inc. engages in medical industry. It provides services which are dedicated to the discovery, development, and commercialization of transformative and personalized cellular therapeutics. The company was founded by Samuel Strober, Edgar Engleman, Robert Lowsky, and Chih Ping in 2012 and is headquartered in South San Francisco, CA.
4
| Holding Company | Medical/Nursing Services | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Michael Zdanowski via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| MODERNA, INC. | Biotechnology | Director/Board Member Founder | |
| University of Toronto | College/University | Undergraduate Degree Graduate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| THE GOLDMAN SACHS GROUP, INC. | Investment Banks/Brokers | Compliance Officer Corporate Officer/Principal | |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ACCELERON PHARMA INC. | Biotechnology | Chairman Director/Board Member | |
| INTELLIA THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Founder | |
Frontera Therapeutics, Inc.
 Frontera Therapeutics, Inc. BiotechnologyHealth Technology Frontera Therapeutics, Inc. is an American biotechnology company that focuses on the research and development of innovative drugs for various diseases such as eye, blood, genetic metabolism, neuromuscular, and others. The company is based in Shanghai, China, and has subsidiaries in Suzhou, China. Frontera Therapeutics specializes in producing high-quality and affordable recombinant adeno-associated virus (rAAV) carrier gene therapy products to meet the treatment needs of hereditary and chronic diseases. The company was founded in September 2019 by Hongyuan Capital and Obo Capital Investment, and it brings together professionals with rich experience in drug research and development, clinical research, registration, and production management. | Biotechnology | Director/Board Member | |
| KYMERA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| CULLINAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Robert W. Baird & Co., Inc. /Venture Partners/
 Robert W. Baird & Co., Inc. /Venture Partners/ Investment ManagersFinance Robert W. Baird & Co., Inc./Venture Partners/ (Baird Venture) is a venture capital division of Robert W. Baird & Co., Inc. founded in 2000 by Thomas Desmond. The firm is headquartered in Chicago, Illinois. | Investment Managers | Private Equity Investor | |
Impresa Management LLC
 Impresa Management LLC Investment ManagersFinance Impresa Management LLC(Impresa Management) is a Private Equity/Venture Capital firm, a subsidiary of Devonshire Investors LLC founded in 1946.The firm is headquartered in Boston. | Investment Managers | Private Equity Investor | |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Market Strategist | |
Ivenix, Inc.
 Ivenix, Inc. Medical SpecialtiesHealth Technology Ivenix, Inc. operates as a medical device company. It develops and supplies infusion systems and intravenous-infusion pumps that eliminate air in the fluid bag line. The company was founded by John L. Bakos and Jeffrey Carlisle in 2007 and is headquartered in Amesbury, MA. | Medical Specialties | Director/Board Member | |
6 Dimensions Capital
 6 Dimensions Capital Investment ManagersFinance 6 Dimensions Capital is an independent private equity firm headquartered in China. The firm was founded in 2017. | Investment Managers | Private Equity Investor | |
| ALTHEADX INC | Pharmaceuticals: Major | Chief Executive Officer | |
| TCR2 THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Biotechnology | Founder | |
| CSTONE PHARMACEUTICALS | Pharmaceuticals: Major | Director/Board Member | |
Creacion Ventures Management LLC
 Creacion Ventures Management LLC Investment ManagersFinance Creacion Ventures Management LLC (Creacion Ventures) is a venture capital firm founded in 2020. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
| China University of Science & Technology | College/University | Undergraduate Degree | |
| American University | College/University | Undergraduate Degree | |
LifeMine Therapeutics, Inc.
 LifeMine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LifeMine Therapeutics, Inc. develops drugs from fungi which aims to cure untreatable and significant chronic diseases. The company was founded by Gregory L. Verdine, WeiQing Zhou, Richard D. Klausner and Hingge Hsu and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Condé Nast Entertainment, Inc.
 Condé Nast Entertainment, Inc. Movies/EntertainmentConsumer Services Condé Nast Entertainment, Inc. develops film, television, and premium digital video programming. The firm's portfolio include Vogue, Vanity Fair, Glamour, Brides, Self, GQ, GQ Style, The New Yorker, Condé Nast Traveler, Allure, Architectural Digest, Bon Appétit, Epicurious, Wired, W, Golf Digest, Golf World, Teen Vogue, Ars Technica, The Scene, Pitchfork and Backchannel. The company was founded by Conde Montrose Nast and Pat Connolly in 2011 and is headquartered in New York, NY. | Movies/Entertainment | Public Communications Contact | |
| Kellogg School of Management | College/University | Masters Business Admin | |
| OCUMENSION THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
| INNOVENT BIOLOGICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Creacion Ventures GP I LLC | Corporate Officer/Principal | ||
Eight Roads Capital Advisors (Hong Kong) Ltd.
 Eight Roads Capital Advisors (Hong Kong) Ltd. Investment ManagersFinance Eight Roads Capital Advisors (Hong Kong) Ltd(Eight Roads Capital) is a venture capital firm founded in 1900. Headquartered in Hong Kong. | Investment Managers | Corporate Officer/Principal | |
Dewpoint Therapeutics, Inc.
 Dewpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dewpoint Therapeutics, Inc. develops drugs. The company is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
Shanghai Fangrun Medical Technology Co., Ltd.
 Shanghai Fangrun Medical Technology Co., Ltd. Electronic Equipment/InstrumentsElectronic Technology Forerunner Medical Equipment Technology Shanghai Co. Ltd. engages in the manufacture, sale of pharmaceutical products and medical equipment. The company was founded by Jie Qin in 2009 and is headquartered in Shanghai, China. | Electronic Equipment/Instruments | Director/Board Member | |
| AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Connecticut Business & Industry Association
 Connecticut Business & Industry Association Miscellaneous Commercial ServicesCommercial Services Connecticut Business & Industry Association is a non-profit organization that provides commercial support services. The private company is based in Hartford, CT. Joseph F. Brennan has been the CEO of the company since 1988. | Miscellaneous Commercial Services | Director/Board Member | |
Semma Therapeutics, Inc.
 Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director of Finance/CFO | |
GeneChem Management, Inc.
 GeneChem Management, Inc. Investment ManagersFinance GeneChem Management Inc (GeneChem) is an independent venture capital firm founded in 1997. The firm is headquartered in Montréal. | Investment Managers | Corporate Officer/Principal | |
Abide Therapeutics, Inc.
 Abide Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Abide Therapeutics, Inc. develops medicines that target serine hydrolases. Its approach is to selectively block serine hydrolases, potentially expanding this class of commercially validated enzymes as targets in a range of indications. The firm has a technology platform that exploits a chemoproteomics approach to selectively target serine hydrolases and rapidly identify target lead pairs. The company was founded by Alan B. Ezekowitz, Dale Boger, John Kennedy Clarke, Benjamin F. Cravatt, Todd Jones, Keith F. Lenden, and Paul R. Schimmel in 2011 and is headquartered in San Diego, CA. | Pharmaceuticals: Other | Director of Finance/CFO | |
| SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. II | Financial Conglomerates | Director/Board Member | |
| AURA BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
| NUVALENT, INC. | Biotechnology | Director/Board Member | |
| BIOPLUS ACQUISITION CORP. | Financial Conglomerates | Corporate Officer/Principal | |
| New York University School of Medicine | College/University | Doctorate Degree | |
Alumis, Inc.
 Alumis, Inc. Pharmaceuticals: MajorHealth Technology Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
| INNOVIVA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Jp Morgan Direct Corporate Finance | Corporate Officer/Principal | ||
Trickle Up Program, Inc.
 Trickle Up Program, Inc. Miscellaneous Commercial ServicesCommercial Services Trickle Up Program, Inc. is an organization that aims to end extreme poverty by partnering with women. The non-profit company is based in New York, NY. The company believes that women are agents of change and key to breaking the intergenerational cycle of poverty. The organization invests in women and provides them with training and mentoring to build sustainable livelihoods and transform their futures. Trickle Up has reached many lives since 1979 and supports savings groups. The company works through partners and provide coaching in displaced contexts. | Miscellaneous Commercial Services | Director/Board Member |
Statistics
International
| United States | 39 |
| China | 6 |
| Canada | 3 |
| Switzerland | 2 |
| Taiwan | 2 |
Sectoral
| Health Technology | 27 |
| Finance | 10 |
| Consumer Services | 8 |
| Commercial Services | 5 |
| Electronic Technology | 2 |
Operational
| Director/Board Member | 144 |
| Independent Dir/Board Member | 45 |
| Corporate Officer/Principal | 44 |
| Chairman | 27 |
| Chief Executive Officer | 25 |
Most connected contacts
| Insiders | |
|---|---|
| Paul Meister | 43 |
| Nicholas G. Galakatos | 38 |
| Karen Smith | 30 |
| Francois Nader | 28 |
| Wei Li | 24 |
| Frank Kung | 22 |
| Sapna R. Srivastava | 22 |
| Giovanni A. Ferrara | 15 |
| Stephen Scherr | 14 |
| Mary Fenton | 10 |
| Derrick J. Rossi | 10 |
| Gaurav D. Shah | 8 |
| Andrew Farnsworth | 8 |
| Douglass H. Laidlaw | 5 |
| Colby Suire | 4 |
- Stock Market
- Insiders
- Michael Zdanowski
- Company connections
